Marker Therapeutics shareholders approve increase in authorized shares from 30M to 130M

the Company’s stockholders approved an amendment to the Company’s Certificate of Incorporation, as amended, to increase the number of authorized shares of our Common Stock from 30,000,000 shares of Common Stock to 130,000,000 shares of Common Stock (the “ Charter Amendment ”).

Proposal No. 2 : Approval, on an advisory basis, of the compensation of the Company’s named executive officers. The votes were cast as follows: Votes For Votes Against Abstained Advisory approval of named executive officer compensation 8,548,905 471,261 552,789 Broker Non-Votes: 2,804,902.

Proposal No. 6 : Approval of the adjournment of the Annual Meeting in the event that the number of shares of Common Stock present or represented by proxy at the Annual Meeting and voting "FOR" the adoption of Proposal 3 is insufficient. The votes were cast as follows: Votes For Votes Against Abstained Adjournment 11,264,545 1,003,337 109,974 Broker Non-Votes: 0.

Proposal No. 1 : Election of five nominees to serve as directors until the 2027 annual meeting of stockholders and until their respective successors are elected and qualified. The votes were cast as follows: Name Votes For Votes Withheld David Eansor 9,297,478 275,480 Steven Elms 9,347,549 225,409 Katharine Knobil 9,314,762 258,196 Juan Vera 9,331,093 241,865 Kathryn Penkus Corzo 9,377,143 195,815 Broker Non-Votes: 2,804,902.

Proposal No. 3: Approval of the adoption of an amendment to our Certificate of Incorporation, as amended, to increase the number of authorized shares of our Common Stock from 30,000,000 shares of Common Stock to 130,000,000 shares of Common Stock. The votes were cast as follows: Votes For Votes Against Abstained Approval of Charter Amendment to Increase Authorized Common Stock. 10,851,228 1,412,017 114,611 Broker Non-Votes: 0.

Proposal No. 4: Approval of the adoption of an amendment to our Certificate of Incorporation, as amended, to revise the voting threshold required for an increase or decrease of Common Stock. The votes were cast as follows: Votes For Votes Against Abstained Approval of Charter Amendment to Revise Voting Threshold 8,279,190 1,222,558 71,209 Broker Non-Votes: 2,804,902.

Proposal No. 5 : Ratification of the selection by the Audit Committee of the Board of Directors of CBIZ CPAs P.C. ("CBIZ") as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. The votes were cast as follows: Votes For Votes Against Abstained Ratification of appointment of CBIZ 11,626,068 1,003,337 109,974 Broker Non-Votes: 0.